July 04, 2025

Respiratory Disease: From Scarcity to Solutions

How low-resource-focused innovations in biomarker diagnostics are shaping the future of global health

The Pathologist

July 02, 2025

UK Plans Nationwide DNA Sequencing of Newborns

The scheme aims to prevent disease, but some experts are skeptical

The Analytical Scientist

June 27, 2025

Weight Loss Drugs, Heavier Implications

New guidance positions GLP-1 and GLP-1/GIP therapies as frontline options for long-term weight management—with profound implications for cardiovascular outcomes, access equity, and chronic disease care.

Conexiant

July 23, 2024

Infant With Severe Lung Immaturity and Pulmonary Hypertension Is Thriving

A pneumatocele that occupied almost the entirety of Baby P’s right lower lung was becoming life-threatening. But with help from the Chronic Lung Care team at Mount Sinai Kravis Children’s Hospital, he is now doing well.

Mount Sinai New York

February 03, 2025

Improving PTSD Treatment for Female Veterans When Gold Standard Fails

For female veterans with post-traumatic stress disorder, sometimes the gold standard treatment isn’t sufficient. A Mount Sinai study aims to tackle this problem by combining it with an intervention designed by its researchers that had been validated in previous studies.

Mount Sinai New York

July 11, 2023

Novel JAMA Study on Diabetic Foot Ulcers: Best Practices for Treatment and Prevention

Diabetic foot ulcers are a “silent, sinister syndrome” that contribute to far too many amputations and deaths, said David G. Armstrong, DPM, PhD, a podiatric surgeon at Keck Medicine of USC.

Keck Medicine of USC

October 31, 2024

First-in-Class Therapy for Ulcerative Colitis Proves Effective in Clinical Trial

Tulisokibart, a monoclonal antibody designed specifically to bind to TL1A, a protein involved in the inflammatory process of ulcerative colitis, proved safe and effective in a phase 2 trial involving patients who had failed other therapies. It is the first drug in its class and would provide a novel treatment pathway for these patients.

Mount Sinai New York

October 31, 2024

Mount Sinai Researchers Enhance Screening Methods to Prevent Spread of Drug-Resistant Fungal Infections in Hospitals

Expanded protocols promote early detection in high-risk patients and prevent hospital outbreaks of Candida auris.

Mount Sinai New York

July 18, 2023

Mount Sinai Helps Set the Standards For Hep B Screening and Vaccination Worldwide

Mount Sinai Health System is leading the fight against hepatitis B, having launched a universal screening and vaccination campaign across New York City in the fall of 2022, while heading up the development of a bold new set of guidelines to streamline testing, diagnosis, and management of the disease.

Mount Sinai New York